{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:46:11Z","timestamp":1767649571085,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jcv.2023.105471","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T13:30:57Z","timestamp":1682429457000},"page":"105471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Polio type 2 and 3 eradication: Relevance to the immunity status of individuals living in Germany, 2005\u20132020"],"prefix":"10.1016","volume":"164","author":[{"given":"Niko","family":"Kohmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger F.","family":"Rabenau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Rilling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Ciesek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Enders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maren","family":"Eggers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2015","series-title":"14th Meeting of the Global Commission for the Certification of Poliomyelitis Eradication (GCC)","key":"10.1016\/j.jcv.2023.105471_bib0001"},{"year":"2019","series-title":"Report from the Twentieth Meeting of the Global Commission for Certification of Poliomyelitis Eradication","key":"10.1016\/j.jcv.2023.105471_bib0002"},{"key":"10.1016\/j.jcv.2023.105471_bib0003","unstructured":"Robert Koch Institut, Impfempfehlungen Im \u00dcberblick. https:\/\/www.rki.de\/DE\/Content\/Kommissionen\/STIKO\/Empfehlungen\/Archiv\/Tab_Einf_Impfempfehlungen_Dtl.pdf?__blob=publicationFile."},{"key":"10.1016\/j.jcv.2023.105471_bib0004","unstructured":"Robert Koch Institut, National Reference Centre For Poliomyelitis and Enteroviruses (NRC PE). https:\/\/www.rki.de\/EN\/Content\/infections\/Diagnostics\/NatRefCentresConsultantLab\/POLIO\/Polio_node.html."},{"key":"10.1016\/j.jcv.2023.105471_bib0005","unstructured":"Global Polio Eradication Initiative, Endemic Countries. https:\/\/polioeradication.org\/where-we-work\/polio-endemic-countries\/ (accessed 30.12.22)."},{"key":"10.1016\/j.jcv.2023.105471_bib0006","doi-asserted-by":"crossref","first-page":"538","DOI":"10.15585\/mmwr.mm7115a2","article-title":"Surveillance to track progress toward polio eradication - worldwide, 2020-2021","volume":"71","author":"Wilkinson","year":"2022","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"year":"2022","series-title":"Global Polio Eradication Initiative, Global Wild Poliovirus 2016 - 2022","key":"10.1016\/j.jcv.2023.105471_bib0007"},{"key":"10.1016\/j.jcv.2023.105471_bib0008","unstructured":"Global Polio Eradication Initiative, Polio Now: A Map Showing the Latest Number of WPV1 and cVDPV Cases in Each Affected Country. https:\/\/polioeradication.org\/polio-today\/polio-now\/ (accessed 30.12.22)."},{"key":"10.1016\/j.jcv.2023.105471_bib0009","unstructured":"New York State Department of Health, New York State Department of Health and Rockland County Department of Health Alert the Public to A Case of Polio In the County. https:\/\/www.health.ny.gov\/press\/releases\/2022\/2022-07-21_polio_rockland_county.htm (accessed 30.12.22)."},{"key":"10.1016\/j.jcv.2023.105471_bib0010","unstructured":"New York State Department of Health, Urging Immunization, State Department of Health Updates New Yorkers On Polio Detected In New York State. https:\/\/www.health.ny.gov\/press\/releases\/2022\/2022-08-04_polio_detected_nys.htm (accessed 30.12.22)."},{"key":"10.1016\/j.jcv.2023.105471_bib0011","unstructured":"Government of Israel, Ministry of Health, Polio: History and Current Status of Polio in Israel. https:\/\/www.gov.il\/en\/departments\/guides\/disease-polio?chapterIndex=2 (accessed 30.12.22)."},{"key":"10.1016\/j.jcv.2023.105471_bib0012","unstructured":"World Health Organization, Circulating Vaccine-Derived Poliovirus Type 3 \u2013 Israel. https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2022-DON366 (accessed 30.12.22)."},{"key":"10.1016\/j.jcv.2023.105471_bib0013","unstructured":"UK Health Security Agency, Poliovirus Detected in Sewage from North and East London. https:\/\/www.gov.uk\/government\/news\/poliovirus-detected-in-sewage-from-north-and-east-london (accessed 30.12.22)."},{"key":"10.1016\/j.jcv.2023.105471_bib0014","unstructured":"International Society for Infectious Diseases (ISID), ProMED, PRO\/EDR>Poliomyelitis Update (47): Indonesia Outbreak, RFI. https:\/\/promedmail.org\/promed-post\/?id=8706960 (accessed 30.12.22)."},{"key":"10.1016\/j.jcv.2023.105471_bib0015","unstructured":"Global Polio Eradication Initiative, The Vaccines - OPV. https:\/\/polioeradication.org\/polio-today\/polio-prevention\/the-vaccines\/opv\/ (accessed 30.12.22)."},{"key":"10.1016\/j.jcv.2023.105471_bib0016","unstructured":"Global Polio Eradication Initiative, cVDPV2 Outbreaks and the Type 2 Novel Oral Polio Vaccine (nOPV2). https:\/\/polioeradication.org\/wp-content\/uploads\/2022\/01\/GPEI_cVDPV2-nOPV2_Factsheet_13-Jan-2022-EN.pdf (accessed 30.12.22)."},{"key":"10.1016\/j.jcv.2023.105471_bib0017","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.21.30542","article-title":"Response to a wild poliovirus type 2 (WPV2)-shedding event following accidental exposure to WPV2, the Netherlands, April 2017","volume":"22","author":"Duizer","year":"2017","journal-title":"Euro Surveill."},{"key":"10.1016\/j.jcv.2023.105471_bib0018","unstructured":"World Health Organization, WHO Global Action Plan to Minimize Poliovirus Facility-Associated Risk After Type-Specific Eradication of Wild Polioviruses and Sequential Cessation of Oral Polio Vaccine Use. https:\/\/polioeradication.org\/wp-content\/uploads\/2016\/12\/GAPIII_2014.pdf (accessed 30.12.22)."},{"key":"10.1016\/j.jcv.2023.105471_bib0019","unstructured":"World Health Organization, WHO Global Action Plan for Poliovirus Containment: GAPIV. https:\/\/polioeradication.org\/wp-content\/uploads\/2022\/07\/WHO-Global-Action-Plan-for-Poliovirus-Containment-GAPIV.pdf (accessed 30.12.22)."},{"key":"10.1016\/j.jcv.2023.105471_bib0020","unstructured":"World Health Organization, Statement \u2013 European Region 20 Years Polio-Free: a Celebratory Moment But a Fragile Legacy. https:\/\/www.who.int\/europe\/news\/item\/24-10-2022-statement-european-region-20-years-polio-free-a-celebratory-moment-but-a-fragile-legacy (accessed 30.12.22)."},{"key":"10.1016\/j.jcv.2023.105471_bib0021","unstructured":"European Centre for Disease Prevention and Control, Risk Assessment- Wild-Type Poliovirus 1 Transmission in Israel \u2013 What is the Risk to the EU\/EEA? https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/media\/en\/publications\/Publications\/polio-risk-assessment-transmission-in-Israel.pdf (accessed 30.12.22)."},{"key":"10.1016\/j.jcv.2023.105471_bib0022","first-page":"561","article-title":"Projection of costs of polio eradication compared to permanent control","volume":"221","author":"Zimmermann","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jcv.2023.105471_bib0023","doi-asserted-by":"crossref","first-page":"E70","DOI":"10.1503\/cmaj.110506","article-title":"The role of seroepidemiology in the comprehensive surveillance of vaccine-preventable diseases","volume":"184","author":"Wilson","year":"2012","journal-title":"CMAJ"},{"key":"10.1016\/j.jcv.2023.105471_bib0024","doi-asserted-by":"crossref","first-page":"16074","DOI":"10.1038\/s41598-022-20544-6","article-title":"High-throughput analysis of anti-poliovirus neutralization antibody titre in human serum by the pseudovirus neutralization test","volume":"12","author":"Arita","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jcv.2023.105471_bib0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/21645515.2018.1526553","article-title":"A simple and safe antibody neutralization assay based on polio pseudoviruses","volume":"15","author":"Jiang","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jcv.2023.105471_bib0026","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1002\/jmv.24909","article-title":"A safe and reliable neutralization assay based on pseudovirus to measure neutralizing antibody titer against poliovirus","volume":"89","author":"Liu","year":"2017","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2023.105471_bib0027","unstructured":"World Health Organization, Manual For the Virological Investigation of Polio. WHO\/EPI\/GEN\/97.01."},{"key":"10.1016\/j.jcv.2023.105471_bib0028","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/1471-2334-10-347","article-title":"Immunity status of adults and children against poliomyelitis virus type 1 strains CHAT and Sabin (LSc-2ab) in Germany","volume":"10","author":"Eggers","year":"2010","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jcv.2023.105471_bib0029","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2334-12-24","article-title":"Deficiency of immunity to poliovirus type 3: a lurking danger?","volume":"12","author":"Reinheimer","year":"2012","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jcv.2023.105471_bib0030","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0934-8840(11)80515-3","article-title":"Quantitative detection of neutralizing antibodies against polioviruses and non-polio enteroviruses (NPEV) using an automated microneutralization assay: a seroepidemiologic survey","volume":"280","author":"Weber","year":"1994","journal-title":"Zentralblatt Bakteriol."},{"key":"10.1016\/j.jcv.2023.105471_bib0031","doi-asserted-by":"crossref","DOI":"10.1590\/1984-0462\/2021\/39\/2019354","article-title":"Prevalence of neutralizing antibodies against poliovirus 1, 2, and 3 in healthcare professionals aged 20-50 years","volume":"39","author":"de Moraes","year":"2021","journal-title":"Rev. Paul. Pediatr."},{"key":"10.1016\/j.jcv.2023.105471_bib0032","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1016\/j.vaccine.2021.04.005","article-title":"Long-term persistence of poliovirus neutralizing antibodies in the era of polio elimination: an Italian retrospective cohort study","volume":"39","author":"Bianchi","year":"2021","journal-title":"Vaccine"},{"year":"2022","series-title":"Epidemiologisches Bulletin 48 \/2022: Impfquoten von Kinderschutzimpfungen in Deutschland","key":"10.1016\/j.jcv.2023.105471_bib0033"},{"key":"10.1016\/j.jcv.2023.105471_bib0034","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s00103-022-03538-7","article-title":"Die impfaktion gegen poliomyelitis in der DDR im jahr 1960 am beispiel der Stadt Halle (Saale): historische erfahrungen und probleme","volume":"65","author":"Wanke","year":"2022","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"10.1016\/j.jcv.2023.105471_bib0035","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0140-6736(90)90420-A","article-title":"Immunisation and herd immunity","volume":"335","author":"Anderson","year":"1990","journal-title":"Lancet"},{"year":"2022","series-title":"PAHO Urges Increased Polio Vaccination of Children in the Americas","key":"10.1016\/j.jcv.2023.105471_bib0036"},{"key":"10.1016\/j.jcv.2023.105471_bib0037","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4161\/hv.18444","article-title":"Evaluation of the establishment of herd immunity in the population by means of serological surveys and vaccination coverage","volume":"8","author":"Plans-Rubi\u00f3","year":"2012","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jcv.2023.105471_bib0038","unstructured":"World Health Organization, Coronavirus Disease (COVID-19): Herd immunity, Lockdowns and COVID-19. https:\/\/www.who.int\/news-room\/questions-and-answers\/item\/herd-immunity-lockdowns-and-covid-19 (accessed 30.12.22)."},{"key":"10.1016\/j.jcv.2023.105471_bib0039","unstructured":"Yale Medicine News, Herd Immunity: Will We Ever Get There? https:\/\/www.yalemedicine.org\/news\/herd-immunity (accessed 30.12.22)."},{"key":"10.1016\/j.jcv.2023.105471_bib0040","doi-asserted-by":"crossref","first-page":"12889","DOI":"10.1073\/pnas.1323502111","article-title":"Robustness against serum neutralization of a poliovirus type 1 from a lethal epidemic of poliomyelitis in the Republic of Congo in 2010","volume":"111","author":"Drexler","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138665322300094X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S138665322300094X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:17:22Z","timestamp":1761362242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S138665322300094X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":40,"alternative-id":["S138665322300094X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2023.105471","relation":{},"ISSN":["1386-6532"],"issn-type":[{"type":"print","value":"1386-6532"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polio type 2 and 3 eradication: Relevance to the immunity status of individuals living in Germany, 2005\u20132020","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2023.105471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105471"}}